Appili Therapeutics Inc. (TSX: APLI)

Appili Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Year Ending	Current	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	4	4	5	9	70	32
Market Cap Growth	-12.50%	-12.50%	-43.28%	-87.73%	120.84%	-
Enterprise Value	12	12	9	2	50	30
Last Close Price	0.04	0.04	0.04	0.12	1.11	0.68
PE Ratio	-	-1.12	-0.49	-0.32	-4.59	-4.31
PS Ratio	5.13	5.13	14.52	6.15	-	158.47
PB Ratio	-0.39	-0.39	-0.66	-2.61	5.46	3.57
P/FCF Ratio	-1.70	-1.70	-0.48	-0.45	-6.08	-7.40
P/OCF Ratio	-1.72	-1.72	-0.48	-0.45	-6.09	-7.41
EV/Sales Ratio	14.91	14.08	26.53	1.57	-	151.31
EV/EBITDA Ratio	-1.45	-1.45	-1.12	-0.09	-3.22	-4.93
EV/EBIT Ratio	-1.45	-1.45	-1.12	-0.09	-3.22	-4.91
EV/FCF Ratio	-4.95	-4.67	-0.88	-0.11	-4.40	-7.07
Debt / Equity Ratio	-0.75	-0.75	-1.04	-1.52	0.08	0.11
Debt / FCF Ratio	-3.28	-3.28	-0.76	-0.26	-0.09	-0.24
Asset Turnover	0.36	0.36	0.06	0.10	-	0.02
Quick Ratio	0.11	0.11	0.97	1.21	3.86	7.88
Current Ratio	0.13	0.13	1.05	1.24	3.96	8.06
Return on Equity (ROE)	-	-	-	-529.79%	-132.65%	-81.66%
Return on Assets (ROA)	-217.68%	-217.68%	-86.67%	-115.98%	-66.38%	-42.56%
Return on Capital (ROIC)	-	-	-500.52%	-199.10%	-82.82%	-49.81%
Earnings Yield	-89.08%	-89.08%	-190.55%	-293.71%	-20.56%	-17.17%
FCF Yield	-58.76%	-58.76%	-208.24%	-223.12%	-16.45%	-13.51%
Buyback Yield / Dilution	-6.62%	-6.62%	-70.43%	-12.76%	-72.40%	-13.47%
Total Shareholder Return	-6.62%	-6.62%	-70.43%	-12.76%	-72.40%	-13.47%

Source: S&P Capital IQ. Standard template.